REQUEST A DEMO
Total
USD $0.00
Search more companies

Lonza Biologics Tuas Pte. Ltd. (Singapore)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Lonza Biologics Tuas Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: manufacture of other biological products and preparations for human use (contract manufacturing of biological drug applications/products for human use.); Secondary Business Activity: manufacture of biological products and preparations for veterinary use (contract mfg of biological drug applications/products for veterinary use.)

Headquarters
35 Tuas South Avenue 6, Singapore
Singapore; Singapore; Postal Code: 637377

Contact Details: Purchase the Lonza Biologics Tuas Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Lonza Biologics Tuas Pte. Ltd. report to view the information.
Outstanding Shares:
Purchase the Lonza Biologics Tuas Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Lonza Biologics Tuas Pte. Ltd. report to view the information.
Incorporation Date:
October 04, 2006
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
83.33%
Company Performance
Financial values in the chart are available after Lonza Biologics Tuas Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
6.56%
Total operating revenue
6.56%
Net Profit (Loss) for the Period
-6.7%
Total assets
1.74%
Total equity
-0.99%
Net Profit Margin
-3.64%
Return on Equity (ROE)
-2.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?